In a letter to Peter Marks, director of the Center for Biologics Evaluation and Research, Robert F. Kennedy, Jr. asks the U.S. Food and Drug Administration to take a cautious approach in approving COVID-19 vaccines that have been developed at âwarp speed.â
By Children’s Health Defense Team
On Dec. 4, Robert F. Kennedy, Jr., chairman and chief legal council for Childrenâs Health Defense, sent the below letter to Peter Marks, director of the Center for Biologics Evaluation and Research (CBER), asking the U.S. Food and Drug Administration to take a cautious approach in approving COVID-19 vaccines that have been developed at âwarp speed.â
TAKE ACTION: On Dec. 10, CBERâs Vaccines and Related Biological Products Advisory Committee (VRBPAC) will meet in open session to discuss Emergency Use Authorization of the Pfizer-BioNTech COVID vaccine for the prevention of COVID-19 in individuals 16 years of age and older. Take action below by urging VRBPAC to make safety the chief concern in its considerations:
- Send RFK, Jr.âs letter (see below) to CBER Director Peter Marks and Senator Ron Johnson of Wisconsin, chair of the Senate Homeland Security and Governmental Affairs Committee, who has expressed similar COVID vaccine safety concerns.
- Send the letter in the action alert below to your representatives in the House and Senate letting them know that you support Kennedyâs call for caution in making decisions regarding Emergency Use Authorization of Pfizerâs COVID vaccine as well as any other COVID vaccine in development.
With the VRBPAC meeting coming up so quickly, the time to act is now!